The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Net Asset Value(s)

8 Apr 2021 12:55

RNS Number : 8539U
Aberdeen Emerging Markets Inv Co Ld
08 April 2021
 

Aberdeen Emerging Markets Investment Company Limited (the "Company")

LEI: 213800RIA1NX8DP4P938

The Company announces that as at the close of business on 7 April 2021 its unaudited Net Asset Value (NAV) was:

Net assets (millions)

NAV per ordinary share

£379.3

825.25p

Notes:

The NAV per ordinary share figure is based on 45,965,159 ordinary shares (excluding shares held in treasury) in issue on the above date.

Quoted investments in the Company's portfolio have been valued on a bid price basis in the above calculations. Investments in open-ended funds have been valued using their latest available net asset values.

The above Net Assets and NAV figures include current financial year revenue items.

No adjustment for dilution to the above NAV has been made in respect of any shares held in treasury.

Enquiries:

Aberdeen Standard Fund Managers Limited (Alternative Investment Fund Manager to Aberdeen Emerging Markets Investment Company Limited)

Andrew Lister / Bernard Moody

Tel: +44 (0)20 7618 1440

PraxisIFM Fund Services (UK) Limited (UK Administration Agent)

Brian Smith

Tel: +44 (0)204 513 9260

Ordinary Shares - Listing Category: Premium - Equity Closed-ended Investment Funds

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVUPUCACUPGGGR

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.